全文获取类型
收费全文 | 173290篇 |
免费 | 13551篇 |
国内免费 | 6756篇 |
专业分类
耳鼻咽喉 | 1260篇 |
儿科学 | 2926篇 |
妇产科学 | 2567篇 |
基础医学 | 18886篇 |
口腔科学 | 3616篇 |
临床医学 | 16645篇 |
内科学 | 24412篇 |
皮肤病学 | 2727篇 |
神经病学 | 10818篇 |
特种医学 | 4329篇 |
外国民族医学 | 41篇 |
外科学 | 15288篇 |
综合类 | 28715篇 |
现状与发展 | 20篇 |
预防医学 | 12888篇 |
眼科学 | 3606篇 |
药学 | 20813篇 |
46篇 | |
中国医学 | 7937篇 |
肿瘤学 | 16057篇 |
出版年
2024年 | 273篇 |
2023年 | 1864篇 |
2022年 | 3781篇 |
2021年 | 5723篇 |
2020年 | 4963篇 |
2019年 | 6790篇 |
2018年 | 6366篇 |
2017年 | 5863篇 |
2016年 | 5652篇 |
2015年 | 5825篇 |
2014年 | 11259篇 |
2013年 | 12268篇 |
2012年 | 11135篇 |
2011年 | 11845篇 |
2010年 | 10080篇 |
2009年 | 10029篇 |
2008年 | 9363篇 |
2007年 | 9927篇 |
2006年 | 8914篇 |
2005年 | 7618篇 |
2004年 | 5740篇 |
2003年 | 5195篇 |
2002年 | 4226篇 |
2001年 | 3727篇 |
2000年 | 3116篇 |
1999年 | 2659篇 |
1998年 | 2329篇 |
1997年 | 1989篇 |
1996年 | 1795篇 |
1995年 | 1650篇 |
1994年 | 1374篇 |
1993年 | 1047篇 |
1992年 | 933篇 |
1991年 | 771篇 |
1990年 | 693篇 |
1989年 | 554篇 |
1988年 | 465篇 |
1987年 | 424篇 |
1986年 | 374篇 |
1985年 | 823篇 |
1984年 | 835篇 |
1983年 | 573篇 |
1982年 | 622篇 |
1981年 | 447篇 |
1980年 | 467篇 |
1979年 | 325篇 |
1978年 | 202篇 |
1977年 | 173篇 |
1976年 | 150篇 |
1975年 | 118篇 |
排序方式: 共有10000条查询结果,搜索用时 343 毫秒
41.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
42.
44.
Mei-Yi Wu Yu-Wei Chen Lie-Yee Hung Chii-Hong Lee Hsin-An Chen Yung-Ho Hsu Mai-Szu Wu 《Transplantation proceedings》2019,51(5):1472-1474
IntroductionThe immunosuppressant agents in kidney transplantation (KT) may lead to various complications such as opportunistic infections and malignancies. BK virus associated nephropathy is a significant complication following KT, and it can result in graft failure. BK virus causes tubulointerstitial nephritis, ureter stenosis, and even graft failure in KT recipients with impaired immune system. We described a 63-year-old woman, who was a hepatitis C carrier and on dialysis for 22 years before KT, who received cadaveric-donor KT 2 years previously. She reported decreasing urine output and general weakness. The serum creatinine level was slightly increased from 2.94 to 4.38 mg/dL.MethodsImmunosuppressant medications including prednisolone, everolimus, cyclosporin, and mycophenolate sodium were continued as maintenance therapy post KT. Kidney biopsy was performed due to deterioration of graft function.ResultsThe kidney biopsy showed consistent results with early-stage polyomavirus nephropathy, characterized by focal viral cytopathic changes with positive immunohistochemical signals and mesangial proliferative glomerulonephritis, immune-complex-mediated (Fig 1 and Fig 2). Negative C4d staining at peritubular capillary was reported. The dosage of mycophenolate sodium was tapered from 720 to 360 mg daily and that of everolimus increased from 0.5 to 1.0 mg daily due to BK viral infection with BK nephropathy. The serum creatinine level was 2.75 mg/dL after treatment.ConclusionEarly detection of BK nephropathy and decreasing immunosuppressant agents are the mainstay of treatment. Substituting leflunomide for mycophenolate sodium and increasing dosage of everolimus has been proposed to solve BK nephropathy. We presented that the use of leflunomide in such situation is in a timely manner. 相似文献
45.
46.
47.
《Pancreatology》2022,22(7):864-870
BackgroundMetagenomic next-generation sequencing (mNGS) is increasingly used for the clinical diagnosis of infectious diseases, but there is a paucity of data regarding the application of mNGS in the early diagnosis of infected pancreatic necrosis (IPN).ObjectiveTo investigate the clinical application value of mNGS in the pathogenic diagnosis of IPN.MethodsForty-two patients with suspected IPN were prospectively and consecutively enrolled from August 2019 to August 2021. Blood samples were collected for mNGS and microbial culture simultaneously during fever (T ≥ 38.5 °C). For patients who had indications of surgical interventions, peri-pancreatic specimens were collected for mNGS and microbial culture simultaneously during the first surgical intervention to confirm IPN. The clinical performance of mNGS and microbial culture were compared.ResultsA total of 21 patients (50.0%) were confirmed to have IPN during hospitalization. The sensitivity of blood mNGS was significantly higher than blood culture (95.2% vs. 23.8%, P < 0.001) in diagnosing IPN. The negative predictive value of blood mNGS was 90.0%. The turnaround time of mNGS was significantly shorter than that of microbial culture [(37.70 ± 1.44) vs. (115.23 ± 8.79) h, P < 0.01] and the average costs of mNGS accounted for 1.7% of the average total cost of hospitalization. The survival analysis demonstrates that the positive blood mNGS result was not associated with increased mortality (P = 0.119).ConclusionsWith more valuable diagnostic performance and shorter turnaround time, clinical mNGS represents a potential step forward in the early diagnosis of IPN. 相似文献
48.
49.
50.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461